Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2004
05/13/2004US20040091476 Enhance or suppress T-cell activation and proliferation
05/13/2004US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation
05/13/2004US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system
05/13/2004US20040091461 Urinary tract tissue graft compositions and methods for producing same
05/13/2004US20040091460 Preparation of spheroids
05/13/2004CA2504179A1 Composition for culturing multipotent stem cells and utilization of the same
05/13/2004CA2503697A1 Trimeric binding proteins for trimeric cytokines
05/13/2004CA2500863A1 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
05/13/2004CA2485342A1 Humanized antibodies against the venezuelan equine encephalitis virus
05/12/2004EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
05/12/2004EP1418228A1 Macroencapsulated secretory cells
05/12/2004EP1418185A1 Use of EDG2 receptor in an animal model of heart failure
05/12/2004EP1418183A1 Cystic fibrosis gene
05/12/2004EP1417485A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
05/12/2004EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
05/12/2004EP1417338A1 Genes and snps associated with eating disorders
05/12/2004EP1417320A2 Transgenic plants expressing cobalamin binding proteins
05/12/2004EP1417315A2 Plant ion channels and methods
05/12/2004EP1417309A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
05/12/2004EP1417304A2 Method and composition for inhibiting heparanase activity
05/12/2004EP1417302A2 Kinase crystal structures and materials and methods for kinase activation
05/12/2004EP1417300A1 Process for the maturation of dentritic cells and a vaccine
05/12/2004EP1417299A1 New biopesticide using gene from erwinia pyrifoliaewt 3, novel pathogen that affects asian pear trees
05/12/2004EP1417234A2 Recombinant anti-plasmodium falciparum antibodies
05/12/2004EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/12/2004EP1417231A2 Modified human thymic stromal lymphopoietin
05/12/2004EP1417229A2 Methods and compounds for the targeting of protein to exosomes
05/12/2004EP1417226A1 Derp1 and proderp1 allergen derivatives
05/12/2004EP1417224A2 Secreted proteins
05/12/2004EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same
05/12/2004EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors
05/12/2004EP1416973A2 Modulation of mhc class i antigen presentation
05/12/2004EP1416956A2 Autologous t-cell vaccines materials and method
05/12/2004EP1416943A1 Tissue implants and methods for making and using same
05/12/2004EP1416888A2 Meniscus regeneration device and method
05/12/2004EP1416887A2 Cartilage repair and regeneration device and method
05/12/2004EP1416886A2 Cartilage repair and regeneration scaffold and method
05/12/2004EP1416880A2 Cartilage repair apparatus and method
05/12/2004EP1416879A2 Unitary surgical device and method
05/12/2004EP1416874A2 Hybrid biologic/synthetic porous extracellular matrix scaffolds
05/12/2004EP1416866A2 Devices form naturally occurring biologically derived
05/12/2004EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals
05/12/2004EP1151756A4 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus
05/12/2004EP1137781B1 Mutants of rna polymerases with increased stability
05/12/2004EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis
05/12/2004EP1017269A4 Plant genes for sensitivity to ethylene and pathogens
05/12/2004EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1
05/12/2004EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
05/12/2004EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same
05/12/2004EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR
05/12/2004EP0785999B1 Plant transcription regulators from circovirus
05/12/2004EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation
05/12/2004EP0627912B1 Gels for encapsulation of biological materials
05/12/2004EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides
05/12/2004CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease
05/12/2004CN1496370A Isolated GUM operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
05/12/2004CN1496367A Materials and methods for producing tomato yellow leaf curl virus resistance in plants
05/12/2004CN1495262A Non-splicing variant of gp 350/220
05/12/2004CN1495257A New recombinant xylanase capable of deriving self-anaerobic mycetes, its related sequence, expression vector and host
05/12/2004CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method
05/12/2004CN1495195A Transgenic animal for expressing androgen receptor compound relatea protein
05/12/2004CN1149293C Male tissue-perferred regulatory region and method of using same
05/12/2004CN1149290C Novel Human Lysozyme gene, its encodling polypeptide and the method for preparing them
05/12/2004CN1149289C Promoter from ashbya gossypii
05/12/2004CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
05/11/2004US6734344 Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1
05/11/2004US6734342 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide
05/11/2004US6734340 Monocotyledon plant cells and plants which synthesise modified starch
05/11/2004US6734339 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering
05/11/2004US6734338 Using composition for in vitro and in vivo transfection of vertebrate male germ cells comprising a nucleic acid or transgene and a gene delivery system, and optionally a protective internalizing agent
05/11/2004US6734337 Activation of fatty acid oxidation and weight reduction; obtain human, administer enzyme inhibitor, monitor humans for decrease in weight and increase in fatty acid oxidation
05/11/2004US6734295 Modified CRE recombinase gene for mammals
05/11/2004US6734289 Gastrokines and derived peptides including inhibitors
05/11/2004US6734288 Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage
05/11/2004US6734286 Interleukin-5 specific recombinant antibodies
05/11/2004US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence
05/11/2004US6734170 Cellular uptake of bioactive agents
05/11/2004US6734160 Nucleotide sequences coding polypeptide for use in the treatment of diabetes
05/11/2004US6734018 Prepartion of soft tissue graft for implantation into a mammals; obtain tissue, expose to enzymes and detergents, wash, recover tissue graft, immerse in storage solution
05/11/2004US6734017 Gene expression inhibition; antiproliferative, anticancer and antiarthritic agents; angiogenesis inhibitors
05/11/2004US6734016 Method for culturing cell and a culture vessel
05/11/2004US6734015 Capable of self-renewal and differentiation into neurons, but not into glia, i.e. astrocytes and oligodendrocytes
05/11/2004US6734014 For diagnosis and treatment of cancers and cellular infections; antigen presenting cell activates t cells against major histocompatibility coplex class i antigens; immunotherapy
05/11/2004US6734003 Phosphodiesterase 10
05/11/2004US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr)
05/11/2004US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4
05/11/2004US6733980 Diagnostic method for detection of molecular forms of eosinophilic cationic protein (ISO-ECPS)
05/11/2004US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/11/2004US6733973 Diagnostic reagents for human cytomegalovirus and methods of use
05/11/2004US6733755 Ligand for vascular endothelial growth factor receptor
05/11/2004US6733748 Chronic lymphocytic leukemia treatment
05/11/2004US6733747 Prosthetic grafts
05/11/2004US6733746 Culture product; cell differentiation
05/11/2004CA2218358C Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same
05/11/2004CA2074188C Vector with multiple tat activation response elements affecting gene expression
05/07/2004CA2448481A1 A cell therapy method for the treatment of tumors
05/06/2004WO2004038368A2 Device and method for monitoring leukocyte migration
05/06/2004WO2004038367A2 Biological assays using gradients formed in microfluidic systems
05/06/2004WO2004038012A1 The feeder cell layer for in vitro culturing human embryonic stem cells and the method for culturing embryonic stem cells
05/06/2004WO2004038011A1 The htert gene-transduced human neural stem cells, the method for establishing and identifying them